Our Mission
Advancing Research Through
Uncompromising Purity.
NexGen BioResearch was founded on a single conviction: researchers deserve complete transparency about the compounds they work with. Every operational decision we make — from supplier selection to COA publication — flows from that commitment.
Why We Exist
The Research Peptide Market Needed a Different Standard
When we began researching the peptide supply chain, we found a category defined by opacity: compounds sold without independent verification, COAs that appeared self-generated, and vendors with no disclosed quality control protocol.
We built NexGen BioResearch to be the alternative. Every compound we sell is tested by an ISO 17025 accredited external laboratory before release. Every Certificate of Analysis is published in our publicly searchable database — whether the batch passes or fails.
We operate strictly within FDA guidelines for research chemical suppliers. All compounds are sold for in-vitro laboratory research use only, with mandatory researcher attestation for every order.
≥99%
Average Purity
Across all active batches
0
Hidden Failures
Failed COAs are published
100%
Third-Party Tested
No in-house testing
48hr
Fulfillment
From confirmed order
Quality Infrastructure
Our Lab Standards
These are not marketing claims. They are operational protocols with documented evidence files available to wholesale accounts and institutional partners.
Third-Party Testing Only
We do not perform in-house purity testing. Every batch is sent to an ISO 17025 accredited external laboratory. No exceptions. This eliminates any conflict of interest in our results.
Full-Panel Analysis
Each batch undergoes HPLC purity determination, mass spectrometry identity confirmation, endotoxin testing (LAL assay), and residual solvent screening. The full panel is published.
Minimum 99% Purity Standard
Any batch that tests below 98.5% purity is quarantined and never released for sale. The failed COA is still published in our database — we do not hide failed results.
Dual Supplier Chain
We maintain relationships with multiple ISO 9001-certified manufacturers. Each supplier provides facility documentation, GMP compliance evidence, and is subject to our testing protocol before any batch is accepted.
Cold Chain Integrity
Temperature-sensitive peptides ship with validated cold pack insulation systems. All packaging is tamper-evident. QR codes on each vial link directly to the batch COA record.
Researcher Attestation Required
Every order requires a timestamped digital researcher attestation confirming laboratory research use. This log is maintained and associated with each order record.
From Supplier to Your Lab
Quality Control Process
Supplier Qualification
ISO 9001 certification, facility audit documentation, and sample testing before establishing a supplier relationship.
Incoming Quarantine
All inventory is quarantined upon receipt pending third-party lab results. Nothing ships until testing is complete and passes.
ISO 17025 Lab Testing
Full panel: HPLC purity, mass spectrometry, endotoxin, residual solvents. Results typically returned in 7–14 business days.
COA Publication
Passing batches receive a QR-coded lot label. The COA is uploaded to the public database before the batch is released for sale.
Cold Chain Packaging
Tamper-evident packaging with validated cold insulation. QR code on each vial links to the live COA database.
Compliance Review
Each product page and order communication is reviewed against our attorney-drafted compliance checklist before and after launch.
Regulatory Position
Compliance & Transparency
Research-Use Classification
All NexGen BioResearch compounds are classified and sold strictly as in-vitro research chemicals. They are not drugs, supplements, food products, or cosmetics as defined by FDA regulations.
Researcher Attestation Protocol
Every purchase requires a non-pre-checked digital attestation confirming the buyer is a qualified researcher purchasing for laboratory use only. This attestation is timestamped and logged with the order record, IP address, and customer email.
Labeling Compliance
All product labels and marketing copy undergo attorney review prior to publication. Prohibited content includes: health claims, disease treatment or prevention claims, dosing guidance, and testimonials implying human use.
Regulatory Attorney on Retainer
We maintain an active retainer with a regulatory attorney specializing in FDA enforcement and research chemical compliance. All new products and marketing materials are reviewed before publication.
Ready to Start Your Research?
Browse our complete catalog of ISO 17025-verified research compounds.